• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三价减毒活流感疫苗预防日托中心幼儿流感的成本效益

Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.

作者信息

Hibbert Clare L, Piedra Pedro A, McLaurin Kimmie K, Vesikari Timo, Mauskopf Josephine, Mahadevia Parthiv J

机构信息

RTI Health Solutions, Williams House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, United Kingdom.

出版信息

Vaccine. 2007 Nov 19;25(47):8010-20. doi: 10.1016/j.vaccine.2007.09.018. Epub 2007 Sep 25.

DOI:10.1016/j.vaccine.2007.09.018
PMID:17936446
Abstract

Vaccinating children at day-care may be a cost-effective approach for improving influenza immunization rates in this high-risk group. This study uses influenza attack-rate data from a randomized, blinded, placebo-controlled clinical trial of live-attenuated influenza vaccine, trivalent in day-care centres from two consecutive influenza seasons, one with a moderate attack rate (H1N1 dominant) and one with a high attack rate (H3N2 dominant). Costs were measured in US dollars. In the moderate attack-rate season (vaccinated, 2.2%; placebo, 13.4%), vaccination saved US$ 5.47 per child in societal costs. In the high attack-rate season (vaccinated, 4.7%; placebo, 32.1%), vaccination led to a societal costs savings of US$ 144.44 per child.

摘要

在日托中心为儿童接种疫苗可能是提高这一高危群体流感疫苗接种率的一种具有成本效益的方法。本研究使用了来自一项随机、双盲、安慰剂对照临床试验的流感发病率数据,该试验针对两个连续流感季节在日托中心使用的三价减毒活流感疫苗,其中一个季节流感发病率中等(以H1N1为主),另一个季节发病率高(以H3N2为主)。成本以美元计量。在发病率中等的季节(接种疫苗组为2.2%,安慰剂组为13.4%),接种疫苗使每名儿童的社会成本节省了5.47美元。在发病率高的季节(接种疫苗组为4.7%,安慰剂组为32.1%),接种疫苗使每名儿童的社会成本节省了144.44美元。

相似文献

1
Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.三价减毒活流感疫苗预防日托中心幼儿流感的成本效益
Vaccine. 2007 Nov 19;25(47):8010-20. doi: 10.1016/j.vaccine.2007.09.018. Epub 2007 Sep 25.
2
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.美国24至59个月大儿童中减毒活流感疫苗与灭活流感疫苗的成本效益
Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.
3
Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.减毒活流感疫苗在儿童中的疗效:九项随机临床试验的荟萃分析。
Vaccine. 2009 Feb 11;27(7):1101-10. doi: 10.1016/j.vaccine.2008.11.093. Epub 2008 Dec 16.
4
Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.三价冷适应流感疫苗针对日托幼儿社区获得性、培养确诊流感的安全性、有效性和效力。
Pediatrics. 2006 Dec;118(6):2298-312. doi: 10.1542/peds.2006-0725.
5
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.在患有反复呼吸道感染的幼儿中,减毒活流感疫苗比灭活流感疫苗具有更高的相对效力。
Pediatr Infect Dis J. 2006 Oct;25(10):870-9. doi: 10.1097/01.inf.0000237829.66310.85.
6
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.在2003 - 2004年甲型(H3N2)流感爆发期间接种的三价减毒活鼻内流感疫苗为儿童提供了直接、间接和即时的保护。
Pediatrics. 2007 Sep;120(3):e553-64. doi: 10.1542/peds.2006-2836. Epub 2007 Aug 13.
7
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.三价减毒活疫苗冷适应流感疫苗与三价灭活流感病毒疫苗在哮喘儿童和青少年中的疗效和安全性比较。
Pediatr Infect Dis J. 2006 Oct;25(10):860-9. doi: 10.1097/01.inf.0000237797.14283.cf.
8
Universal influenza vaccination and live attenuated influenza vaccination of children.儿童的通用流感疫苗接种和减毒活流感疫苗接种。
Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S104-9. doi: 10.1097/INF.0b013e318168b729.
9
Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.1剂和2剂减毒活流感疫苗在未接种过疫苗儿童中的有效性和安全性
Pediatr Infect Dis J. 2009 May;28(5):365-71. doi: 10.1097/INF.0b013e31819219b8.
10
Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.具有不同敏感性和特异性水平的临床病例定义对健康在职成年人流感疫苗接种相对和绝对健康益处估计的影响及其对经济分析的意义。
Virus Res. 2004 Jul;103(1-2):3-8. doi: 10.1016/j.virusres.2004.02.005.

引用本文的文献

1
Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review.儿童鼻内减毒活流感疫苗的成本效益:一项系统评价
Vaccines (Basel). 2022 Sep 4;10(9):1466. doi: 10.3390/vaccines10091466.
2
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.季节性流感疫苗经济评估中安全相关问题的纳入:一项系统综述。
Vaccines (Basel). 2021 Feb 2;9(2):111. doi: 10.3390/vaccines9020111.
3
Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature.
干预重大传染病威胁的成本和效益:文献中的经验教训。
Eur J Health Econ. 2020 Dec;21(9):1329-1350. doi: 10.1007/s10198-020-01218-4. Epub 2020 Aug 13.
4
Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009.基于 2001 年至 2009 年的初级和二级保健记录,对英国急性呼吸道疾病的资源利用和直接医疗费用进行分析。
PLoS One. 2020 Aug 6;15(8):e0236472. doi: 10.1371/journal.pone.0236472. eCollection 2020.
5
Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.60月龄及以下泰国儿童队列中季节性流感灭活疫苗接种的成本效益
PLoS One. 2017 Aug 24;12(8):e0183391. doi: 10.1371/journal.pone.0183391. eCollection 2017.
6
Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.美国2至8岁儿童流感疫苗选择的成本效益
Am J Prev Med. 2016 May;50(5):600-608. doi: 10.1016/j.amepre.2015.12.010. Epub 2016 Feb 8.
7
Increasing Coverage of Appropriate Vaccinations: A Community Guide Systematic Economic Review.扩大适当疫苗接种的覆盖范围:《社区指南》系统性经济综述
Am J Prev Med. 2016 Jun;50(6):797-808. doi: 10.1016/j.amepre.2015.11.003. Epub 2016 Feb 1.
8
Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review.与其他儿科免疫规划相比,儿科流感免疫规划的经济学评价:一项系统综述。
Hum Vaccin Immunother. 2016 May 3;12(5):1202-16. doi: 10.1080/21645515.2015.1131369. Epub 2016 Feb 2.
9
Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.扩大英格兰和威尔士针对季节性流感的老年人及风险群体疫苗接种计划:一项成本效益研究。
BMC Med. 2015 Oct 13;13:236. doi: 10.1186/s12916-015-0452-y.
10
Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.使用减毒活流感鼻内疫苗对儿童进行接种——通过卫生技术评估进行分析与评价
GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.